| Valuation of early stage high-tech start-up companies G Festel, M Wuermseher, G Cattaneo International journal of business 18 (3), 216, 2013 | 199 | 2013 |
| Bacterial whole-cell biocatalysts by surface display of enzymes: toward industrial application J Schüürmann, P Quehl, G Festel, J Jose Applied microbiology and biotechnology 98 (19), 8031-8046, 2014 | 165 | 2014 |
| Biofuels–economic aspects GW Festel Chemical Engineering & Technology: Industrial Chemistry‐Plant Equipment …, 2008 | 123 | 2008 |
| Modelling production cost scenarios for biofuels and fossil fuels in Europe G Festel, M Würmseher, C Rammer, E Boles, M Bellof Journal of Cleaner Production 66, 242-253, 2014 | 122 | 2014 |
| Academic spin-offs, corporate spin-outs and company internal start-ups as technology transfer approach G Festel The Journal of Technology Transfer 38, 454-470, 2013 | 102 | 2013 |
| Der einfluss der biotechnologie auf produktionsverfahren in der chemieindustrie G Festel, J Knöll, H Götz, H Zinke Chemie Ingenieur Technik 76 (3), 307-312, 2004 | 50 | 2004 |
| Founding angels as an emerging subtype of the angel investment model in high-tech businesses GW Festel, SH De Cleyn Venture capital 15 (3), 261-282, 2013 | 46 | 2013 |
| Industrial biotechnology: Market size, company types, business models, and growth strategies G Festel Industrial Biotechnology 6 (2), 88-94, 2010 | 46 | 2010 |
| Fermentative production of isobutanol with yeast G Festel, E Boles, C Weber, D Brat US Patent 8,530,226, 2013 | 43 | 2013 |
| Industrial biotechnology--Markets and industry structure. G Festel, C Detzel, R Maas Journal of Commercial Biotechnology 18 (1), 2012 | 39 | 2012 |
| Founding angels as early stage investment model to foster biotechnology start-ups G Festel Journal of Commercial Biotechnology 17, 165-171, 2011 | 36 | 2011 |
| Performance improvement in pharmaceutical R&D through new outsourcing models. G Festel, A Schicker, R Boutellier Journal of Business Chemistry 7 (2), 2010 | 33 | 2010 |
| The chemical and pharmaceutical industry in China: opportunities and threats for foreign companies G Festel, A Kreimeyer, U Oels, M von Zedtwitz Springer Science & Business Media, 2005 | 26 | 2005 |
| Reasons for corporate research and development spin‐outs–the chemical and pharmaceutical industry as example G Festel R&D Management 44 (4), 398-408, 2014 | 25 | 2014 |
| Benchmarking of energy and utility infrastructures in industrial parks G Festel, M Würmseher Journal of Cleaner Production 70, 15-26, 2014 | 22 | 2014 |
| Optimizing the R&D process using spin-outs: Case studies from the pharmaceutical industry G Festel, SH De Cleyn, R Boutellier, J Braet Research-Technology Management 54 (1), 32-41, 2011 | 22 | 2011 |
| Outsourcing of pharmaceutical Manufacturing–a strategic partner selection process G Festel, M De Nardo, T Simmen Journal of Business Chemistry 11 (3), 117-132, 2014 | 20 | 2014 |
| X‐ray investigation of the structure of polyurethane elastomers based on 1, 5‐naphthalene diisocyanate R Androsch, J Blackwell, SN Chvalun, G Festel, CD Eisenbach Acta polymerica 48 (9), 363-368, 1997 | 20 | 1997 |
| Scaling and learning effects of biofuels conversion technologies G Festel, M Würmseher, C Rammer Energy Technology 2 (7), 612-617, 2014 | 19 | 2014 |
| Economic aspects of industrial biotechnology G Festel Sustainability and life cycle assessment in industrial biotechnology, 53-74, 2020 | 18 | 2020 |